Ketamine Injection Shortage
Last Updated: May 3, 2024
Status: Current
Products Affected - Description
-
- Ketalar injection, Par Pharmaceuticals, 10 mg/mL, 20 mL vial, 10 count, NDC 42023-0113-10
- Ketalar injection, Par Pharmaceuticals, 100 mg/mL, 5 mL vial, 10 count, NDC 42023-0115-10
- Ketalar injection, Par Pharmaceuticals, 50 mg/mL, 10 mL vial, 10 count, NDC 42023-0114-10
- Ketamine injection, Eugia US, 10 mg/mL, 20 mL vial, 10 count, NDC 55150-0438-10
- Ketamine injection, Eugia US, 100 mg/mL, 10 mL vial, 10 count, NDC 55150-0440-10
- Ketamine injection, Eugia US, 50 mg/mL, 10 mL vial, 10 count, NDC 55150-0439-10
- Ketamine injection, Hikma, 100 mg/mL, 5 mL vial, 10 count, NDC 00143-9509-10
- Ketamine injection, Hikma, 50 mg/mL, 10 mL vial, 10 count, NDC 00143-9508-10
- Ketamine injection, Pfizer, 100 mg/mL, 5 mL vial, 10 count, NDC 00409-2051-05
- Ketamine injection, Pfizer, 50 mg/mL, 10 mL vial, 10 count, NDC 00409-2053-10
Reason for the Shortage
-
- AuroMedics (Eugia) has ketamine on shortage due to increased demand.
- Hikma has ketamine injection on back order due to shortage of active ingredient.
- Mylan Institutional divested ketamine to AuroMedics.
- Par has Ketalar on back order due to shortage of active ingredient.
- Pfizer has ketamine on shortage due to manufacturing delays.
- Sagent has ketamine injection available.
Available Products
-
- Ketamine injection, Sagent, 10 mg/mL, 20 mL vial, 10 count, NDC 25021-0682-20
- Ketamine injection, Sagent, 100 mg/mL, 5 mL vial, 10 count, NDC 25021-0684-05
- Ketamine injection, Sagent, 50 mg/mL, 10 mL vial, 10 count, NDC 25021-0683-10
Estimated Resupply Dates
-
- Eugia has ketamine 50 mg/mL 10 mL vials and 100 mg/mL 10 mL vials on long-term back order and the company cannot estimate a release date. The 10 mg/mL 20 mL vials are on back order and the company cannot estimate a release date.
- Hikma has ketamine 100 mg/mL 5 mL vials and 50 mg/mL 10 mL vials on allocation.
- Pfizer has ketamine 50 mg/mL 10 mL vials on back order and the company estimates a release date of January 2025. The 100 mg/mL 5 mL vials are available in limited supply.
- Par has all Ketalar presentations on long-term back order and the company cannot estimate a release date.
Alternative Agents & Management
-
- There are practice guidelines available for moderate procedural sedation and analgesia. These are available at https://pubs.asahq.org/anesthesiology/article/128/3/437/18818/Practice-Guidelines-for-Moderate-Procedural.
Updated
Updated May 3, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.